Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Shao-Jing Wang
Institution:
Taichung Veterans General Hospital
Observed institution:
Taichung Veterans General Hospital
ORCID:
0000-0001-7654-2699
Observed ORCID:
0000-0001-7654-2699
OpenAlex ID:
A5078550767
Disparities in medical recommendations from AI-based chatbots across different countries/regions
2024
·
Khanisyah E. Gumilar
, Birama R. Indraprasta
, et al.
·
Scientific Reports
·
40
Menopausal hormone therapy decreases the likelihood of diabetes development in peri‑menopausal individuals with prediabetes
2024
·
Yu-Hsiang Shih
, Chiao-Yu Yang
, et al.
·
Diabetes & Metabolism
·
14
Assessment of adverse pregnancy outcomes associated with Helicobacter pylori infection
2024
·
Shao-Jing Wang
, Chia-Jung Hsieh
, et al.
·
Scientific Reports
·
11
PDF
Lenvatinib plus pembrolizumab compared to carboplatin plus paclitaxel for carboplatin and paclitaxel pretreated, recurrent, or advanced endometrial cancer
2025
·
Shao-Jing Wang
, Lou Sun
, et al.
·
BMC Medicine
·
7
A retrospective study evaluating the effect of trastuzumab addition to carboplatin/paclitaxel on overall survival in patients with advanced-stage HER2/neu-overexpressing uterine serous carcinoma or carcinosarcoma
2025
·
Ting-Fang Lu
, Lou Sun
, et al.
·
BMC Medicine
·
7
PDF
Gestational diabetes: a contributor to long-term thyroid dysfunction and disease
2025
·
Yu-Hsiang Shih
, Chia-Jung Hsieh
, et al.
·
Frontiers in Endocrinology
·
5
PDF
Lenvatinib Plus Pembrolizumab versus Doxorubicin for Advanced or Recurrent Endometrial Cancer with Short Treatment-Free Intervals Following First-Line Carboplatin Plus Paclitaxel
2024
·
Shao-Jing Wang
, Hsin-Hua Chen
, et al.
·
Journal of Clinical Medicine
·
3
PDF
Outcomes of “sandwich” chemoradiotherapy compared with chemotherapy alone for the adjuvant treatment of FIGO stage III endometrial cancer
2022
·
Shao-Jing Wang
, Lily Wang
, et al.
·
Frontiers in Oncology
·
2
PDF
Association of hormone therapy with long-term outcomes after chemoradiation for locally advanced cervical cancer
2026
·
Ting-Fang Lu
, Yu-Hsiang Shih
, et al.
·
American Journal of Obstetrics and Gynecology
·
1
Treatment-Free Interval as a Prognostic Factor for Survival Outcomes in Patients with Advanced or Recurrent Endometrial Cancer Treated with Pembrolizumab Plus Lenvatinib: A Multi-Institutional Real-World Cohort Study
2026
·
Chih-Wen Su
, Shao-Jing Wang
, et al.
·
Cancers
EV250/#838 Comparison of bevacizumab maintenance only with standard bevacizumab throughout treatment in patiens with newly diagnosed advanced ovarian cancer
2024
·
Chun Ting Fan
, Shao-Jing Wang
, et al.
·
International Journal of Gynecological Cancer
PDF
EV164/#394 Lenvatinib, pembrolizumab versus carboplatin, paclitaxel in pretreated, advanced endometrial cancer
2024
·
Shao-Jing Wang
, Sun Lou
, et al.
·
International Journal of Gynecological Cancer
PDF
PR017/#164 Adding trastuzumab to carboplatin and paclitaxel improves overall survival in advanced-stage HER2/NEU overexpressing uterine serous carcinoma or carcinosarcoma
2024
·
Ting-Fang Lu
, Sun Lou
, et al.
·
International Journal of Gynecological Cancer
PDF
Show more works
View as search
Works count:
13
Citation count:
90
H-index:
5
I10-index:
3
Year
Topic
Type
